Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (141-150 of 421) with videos related to

Pageof 43
Sort By:
Research and Practice in Thrombosis and Haemostasis|November 18, 2022
Extended-duration thromboprophylaxis for abdominopelvic surgery: Development and evaluation of a risk-stratified patient decision aid to facilitate shared decision makingVictoria Ivankovic, Kristen McAlpine, Edita Delic, et al.
Thrombosis Research|June 14, 2016
Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot studyLana A Castellucci, Joseph Shaw, Antonio Giulivi, et al.
Thrombosis Research|November 6, 2013
Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patientsSiavash Piran, Vincent Ngo, Sheryl McDiarmid, et al.
Journal of Biomedical Informatics|December 13, 2016
Comprehensive mitigation framework for concurrent application of multiple clinical practice guidelinesSzymon Wilk, Martin Michalowski, Wojtek Michalowski, et al.
Thrombosis Research|August 28, 2024
Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trialTzu-Fei Wang, Ranjeeta Mallick, Abdelrahman Noureldin, et al.
Journal of Thrombosis and Haemostasis : JTH|October 14, 2024
Management and outcomes in patients with tumor thrombus: a retrospective cohort studySean Hui, Khalid Zeid, Roger Kou, et al.
Thrombosis Research|April 15, 2021
Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trialDanyal Ladha, Ranjeeta Mallick, Tzu-Fei Wang, et al.
Journal of Thrombosis and Thrombolysis|March 13, 2019
Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT StudySeth Woodruff, Agnes Y Y Lee, Marc Carrier, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 2014
A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulantsMarc Carrier, Miriam Kimpton, Philip S Wells, et al.
Thrombosis Research|May 6, 2025
Letter-To-The-Editor: Long-term outcomes of patients with isolated subsegmental pulmonary embolism managed without anticoagulant therapyCameron Brown, Ranjeeta Mallick, Amanda Pecarskie, et al.
Pageof 43

Showing results (141-150 of 421) with videos related to

Sort By:
Pageof 43
Research and Practice in Thrombosis and Haemostasis|November 18, 2022
Extended-duration thromboprophylaxis for abdominopelvic surgery: Development and evaluation of a risk-stratified patient decision aid to facilitate shared decision makingVictoria Ivankovic, Kristen McAlpine, Edita Delic, et al.
Thrombosis Research|June 14, 2016
Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot studyLana A Castellucci, Joseph Shaw, Antonio Giulivi, et al.
Thrombosis Research|November 6, 2013
Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patientsSiavash Piran, Vincent Ngo, Sheryl McDiarmid, et al.
Journal of Biomedical Informatics|December 13, 2016
Comprehensive mitigation framework for concurrent application of multiple clinical practice guidelinesSzymon Wilk, Martin Michalowski, Wojtek Michalowski, et al.
Thrombosis Research|August 28, 2024
Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trialTzu-Fei Wang, Ranjeeta Mallick, Abdelrahman Noureldin, et al.
Journal of Thrombosis and Haemostasis : JTH|October 14, 2024
Management and outcomes in patients with tumor thrombus: a retrospective cohort studySean Hui, Khalid Zeid, Roger Kou, et al.
Thrombosis Research|April 15, 2021
Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trialDanyal Ladha, Ranjeeta Mallick, Tzu-Fei Wang, et al.
Journal of Thrombosis and Thrombolysis|March 13, 2019
Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT StudySeth Woodruff, Agnes Y Y Lee, Marc Carrier, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 2014
A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulantsMarc Carrier, Miriam Kimpton, Philip S Wells, et al.
Thrombosis Research|May 6, 2025
Letter-To-The-Editor: Long-term outcomes of patients with isolated subsegmental pulmonary embolism managed without anticoagulant therapyCameron Brown, Ranjeeta Mallick, Amanda Pecarskie, et al.
Pageof 43